Skip to main content

Understanding Design Controls

Compliance Key INC - Medical Device training

                                                     Charles Paul
Charles H. Paul is Keynote Speaker at Compliance key Inc. He is President of C. H. Paul Consulting, Inc. - a regulatory, training, and technical documentation consulting firm. Charles is a management consultant, instructional designer and regulatory consultant and has led C. H. Paul Consulting, Inc. 
 Webinar Id:  LSHCCP008
 12:30 PM PT | 03.30 PM ET 
 01/12/2018
 Duration: 60 mins 
Overview
Design Controls are the processes used to design, develop, and manage medical devices that you manufacture. They are mandated by federal regulation however the regulations concerning design controls are vague in terms of the specific process steps required and the approaches that should be taken to achieve compliance should be developed.

Knowing how the FDA both views and examines design controls is crucial to achieving compliance throughout the life of the medical devices you manufacture and is one of the most valuable compliance subject areas to explore. Noncompliance in design controls, which are consistently uncovered by the FDA during inspections and examinations, are concerned with the design control process that has been designed and applied and the documentation required to support each design control step. The specific sections of the regulations that apply to design controls include CFR 21 Part 820 Quality System regulation found in Sec. 820.30 and Sec. 820.40. These sections of the regulation are extremely complex and difficult to apply particularly for companies that are new to the medical device field. This webinar will explore how design controls should be designed to meet both the spirit and intent of the regulation and the needs of both the medical device itself and the organization.
Why should you attend this webinar?
The number of medical device recalls over the past several years has almost doubled each year indicating that the FDA is increasingly looking at the medical device industry in general and how products are designed and managed in particular. Manufacturers are at significant compliance risk when their design control processes are flawed and are not carefully designed. Compliance risk has significant health and safety implications that medical device companies today can simply not ignore.
Areas Covered in the Session:
  • CFR 21 Part 820 Quality System regulation found in Sec. 820.30 and Sec. 820.40
  • Design control process steps
  • Designing your design control process - the design control planning process
  • Mapping your design control process to the FDA's interpretation of design controls
  • Design inputs and outputs
  • Verification process
  • Validation process
  • Importance of process step documentation
  • Review processes
  • Life cycle management
  • Compound products
  • Medical device applications
Who can Benefit:
Anyone involved in the design, development, and manufacturer of medical devices that has had some exposure to the subject area and regulated environments.
Compliance Key INC
717-208-8666
Or

Comments

Popular posts from this blog

HIPAA Compliance with the New Omnibus Rule: How to Pass an Audit to Avoid Penalties and Criminal Convictions

Compliance Key INC  -  H ipaa webinar                                           Jonathan P. Tomes Jonathan P. Tomes , J.D., is Keynote Speaker at Compliance key Inc. He is a health care attorney practicing in the greater Kansas City.   Webinar Id:   HIPHJPT001  2:30 PM PT | 03:30 PM ET    01/18/2018  Duration: 60 mins  Overview Before the HITECH Act, DHHS could audit covered entities for HIPAA compliance, but did not have to. With that Act, now the must audit those entities and business associates as well. In the first audits, the Phase I audits, DHHS came on site. The subsequent Phase II audits, however, were paper audits in which those audited had to provide documentation of their compliance. As yet, we do not know what form Phase III will take, but the necessary actions to prepar...

HIPAA Compliant Fundraising Under New Rules - 2019

Compliance Key  -  H ipaa   Compliance Training HIPAA Compliant Fundraising Under New Rules - 2019 Joel Simon Joel Simon is one of the nation's leading experts on the fund raising aspects of HIPAA. Joel has been a member of the Maryland bar for 30 years, and his professional experience includes work as the assistant general counsel of a community hospital. Joel is an editor of "Fundraising Under HIPAA" published by the Association of Fundraising Professionals. He has lectured on Fund Raising under HIPAA to national audiences since the original HIPAA regulations were first proposed 17 years ago. Read More Overview Not-for-Profit organizations that are governed by HIPAA often need or want to fund raise from their patients, clients, or families. What protocols should be in place to maximize philanthropic opportunities under HIPAA? What compliance measures need to be in place and assessed to properly use protected health information for fund raisi...

Classifying Medical Devices in US and EU

Compliance Key INC  -  Healthcare Compliance Webinars Overview The Food and Drug Administration (FDA) has established classifications for approximately 1,700 different generic types of devices and grouped them into 16 medical specialties referred to as panels. Each of these generic types of devices is assigned to one of three regulatory classes based on the level of control necessary to assure the safety and effectiveness of the device.The determination process, how you apply the classification process to your device, is complex and requires several levels of analysis to make the proper device classification. Proper medical device classification is the fundamental first step in submitting your device for approval anywhere in the world. This webinar will detail the medical device classification process for the United States through the FDA and will overview the very complex process for medical device classification within the EU. Specifically, this webinar will provid...